A tissue therapeutics company – built on DeepTech innovation – offering a scalable solution to restore lost tissue and organ function for millions of patients.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€7,000,000
Total raised
-
Valuation
29
Employees
2016
Founded
Latest round
Seed - March 25, 2026
Seed - €7,000,000
March 25, 2026
✓ verified by our desk
Open roles
Cellbricks Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile